Abstract
This study aimed to investigate the potential role of pyruvate kinase M2 (PKM2) and extracellular regulated protein kinase (ERK) in arsenic-induced cell proliferation. L-02 cells were treated with 0.2 and 0.4 μmol/L As3+, glycolysis inhibitor (2-deoxy-D-glucose,2-DG), ERK inhibitor [1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)-butadiene, U0126] or transfected with PKM2 plasmid. Cell viability, proliferation, lactate acid production, and glucose intake capacity were determined by CCK-8 assay, EdU assay, lactic acid kit and 2-deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl) amino]-D-glucose (2-NBDG) uptake kit, respectively. Also, levels of PKM2, phospho-PKM2S37, glucose transporter protein 1 (GLUT1), lactate dehydrogenase A (LDHA), ERK, and phospho-ERK were detected using Western blot and the subcellular localization of PKM2 in L-02 cells was detected by immunocytochemistry (ICC). Treatment with 0.2 and 0.4 μmol/L As3+ for 48 h increased the viability and proliferation of L-02 cells, the proportion of 2-NBDG+ cell and lactic acid in the culture medium, and GLUT1, LDHA, PKM2, phospho-PKM2S37, and phospho-ERK levels and PKM2 in nucleus. Compared with the 0.2 μmol/L As3+ treatment group, the lactic acid in the culture medium, cell proliferation and cell viability, and the expression of GLUT1 and LDHA were reduced in the group co-treated with siRNA-PKM2 and arsenic or in the group co-treated with U0126. Moreover, the arsenic-increased phospho-PKM2S37/PKM2 was decreased by U0126. Therefore, ERK/PKM2 plays a key role in the Warburg effect and proliferation of L-02 cells induced by arsenic, and also might be involved in arsenic-induced upregulation of GLUT1 and LDHA. This study provides a theoretical basis for further elucidating the carcinogenic mechanism of arsenic.
Similar content being viewed by others
Data Availability
The authors confirm that the data supporting the findings of this study are available within the article.
References
Wang X, Nie Y, Si B, Wang T, Hei TK, Du H, Zhao G, Chen S, Xu A, Liu Y (2021) Silver nanoparticles protect against arsenic induced genotoxicity via attenuating arsenic bioaccumulation and elevating antioxidation in mammalian cells. J Hazard Mater 413:125287. https://doi.org/10.1016/j.jhazmat.2021.125287
Guber RS, Gonzalez Mac Donald M, Aleman MN, Luciardi MC, Mentz P, Wierna A, Ansonnaud C, Garcia V, Ansonnaud AM, Soria A (2021) Evaluation of salivary protein patterns among a rural population exposed and non-exposed to arsenic-contaminated drinking water in areas of Tucumán (Argentina): a pilot study. J Appl Oral Sci 29e:20200939. https://doi.org/10.1590/1678-7757-2020-0939
Zhang M, Xue Y, Zheng B, Li L, Chu X, Zhao Y, Wu Y, Zhang J, Han X, Wu Z, Chu L (2021) Liquiritigenin protects against arsenic trioxide-induced liver injury by inhibiting oxidative stress and enhancing mTOR-mediated autophagy. Biomed Pharmacother 143:112167. https://doi.org/10.1016/j.biopha.2021.112167
Martinez VD, Lam WL (2021) Health effects associated with pre- and perinatal exposure to arsenic. Front Genet 126:64717. https://doi.org/10.3389/fgene.2021.664717
Sun M, Tan J, Wang M, Wen W, He Y (2021) Inorganic arsenic-mediated upregulation of AS3MT promotes proliferation of nonsmall cell lung cancer cells by regulating cell cycle genes. Environ Toxicol 36(2):204–212. https://doi.org/10.1002/tox.23026
Cheikhi A, Anguiano T, Lasak J, Qian B, Sahu A, Mimiya H, Cohen CC, Wipf P, Ambrosio F, Barchowsky A (2020) Arsenic stimulates myoblast mitochondrial epidermal growth factor receptor to impair myogenesis. Toxicol Sci 176(1):162–174. https://doi.org/10.1002/tox.23026
Sens DA, Park S, Gurel V, Sens MA, Garrett SH, Somji S (2004) Inorganic cadmium- and arsenite-induced malignant transformation of human bladder urothelial cells. Toxicol Sci 79(1):56–63. https://doi.org/10.1093/toxsci/kfh086
Birts CN, Banerjee A, Darley M, Dunlop CR, Nelson S, Nijjar SK, Parker R, West J, Tavassoli A, Rose-Zerilli MJJ, Blaydes JP (2020) p53 is regulated by aerobic glycolysis in cancer cells by the CtBP family of NADH-dependent transcriptional regulators. Sci Signal 13:630. https://doi.org/10.1126/scisignal.aau9529
Wang W, He X, Wang Y, Liu H, Zhang F, Wu Z, Mo S, Chen D (2022) LINC01605 promotes aerobic glycolysis through LDHA in triple-negative breast cancer. Cancer Sci 113(8):2484. https://doi.org/10.1111/cas.15370
Liu J, Yuan JF, Wang YZ (2022) METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate cancer via SRSF1/c-Myc axis. Exp Cell Res 416:113149. https://doi.org/10.1016/j.yexcr.2022.113149
He J, Liu W, Ge X, Wang GC, Desai V, Wang S, Mu W, Bhardwaj V, Seifert E, Liu LZ, Bhushan A, Peiper SC, Jiang BH (2019) Arsenic-induced metabolic shift triggered by the loss of miR-199a-5p through Sp1-dependent DNA methylation. Toxicol Appl Pharmacol 378:114606. https://doi.org/10.1016/j.taap.2019.114606
Bi Z, Zhang Q, Fu Y, Wadgaonkar P, Zhang W, Almutairy B, Xu L, Rice M, Qiu Y, Thakur C, Chen F (2020) Nrf2 and HIF1α converge to arsenic-induced metabolic reprogramming and the formation of the cancer stem-like cells. Theranostics 10(9):4134–4149. https://doi.org/10.7150/thno.42903
Wang Y, Zhao H, Guo M, Fei D, Zhang L, Xing M (2020) Targeting the miR-122/PKM2 autophagy axis relieves arsenic stress. J Hazard Mater 383:383121217. https://doi.org/10.1111/cas.1537014
Luo F, Liu X, Ling M, Lu L, Shi L, Lu X, Li J, Zhang A, Liu Q (2016) The lncRNA MALAT1, acting through HIF-1α stabilization, enhances arsenite-induced glycolysis in human hepatic L-02 cells. Biochim Biophys Acta 1862(9):1685–1695. https://doi.org/10.1016/j.bbadis.2016.06.004
Takenaka M, Yamada K, Lu T, Kang R, Tanaka T, Noguchi T (1996) Alternative splicing of the pyruvate kinase M gene in a minigene system. Eur J Biochem 235(1-2):366–371. https://doi.org/10.1111/j.1432-1033.1996.00366.x
Kamel R, Schwarzfischer F (1975) Pyruvate kinase isozyme patterns of human neoplastic, fetal and adult tissues. Humangenetik 28(1):65–69. https://doi.org/10.1007/BF00272484
Guguen-Guillouzo C, Szajnert MF, Marie J, Delain D, Schapira F (1977) Differentiation in vivo and in vitro of pyruvate kinase isozymes in rat muscle. Biochimie 59(1):65–71. https://doi.org/10.1016/s0300-9084(77)80087-4
Deberardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 7(1):11–20
Dang CV, Kim JW, Gao P, Yustein J (2008) The interplay between MYC and HIF in cancer. Nat Rev Cancer 8(1):51–56. https://doi.org/10.1016/j.cmet.2007.10.002
Wang L, Lu YF, Wang CS, Xie YX, Zhao YQ, Qian YC, Liu WT, Wang M, Jiang BH (2020) HB-EGF activates the EGFR/HIF-1α pathway to induce proliferation of arsenic-transformed cells and tumor growth. Front. Oncol 10:101019. https://doi.org/10.3389/fonc.2020.01019
Yuan Q, Zhang J, Liu Y, Chen H, Liu H, Wang J, Niu M, Hou L, Wu Z, Chen Z, Zhang J (2022) MyD88 in myofibroblasts regulates aerobic glycolysis-driven hepatocarcinogenesis via ERK-dependent PKM2 nuclear relocalization and activation. The Journal of patho 256(4):414–426. https://doi.org/10.1002/path.5856
Lee K, Nam K, Oh S, Lim J, Lee T, Shin I (2015) ECM1 promotes the Warburg effect through EGF-mediated activation of PKM2. Cellular signal 27(2):228–235. https://doi.org/10.1016/j.cbi.2005.04.004
Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, Dimitriadoy S, Liu DL, Kantheti HS, Saghafinia S, Chakravarty D, Daian F, Gao Q, Bailey MH, Liang WW, Foltz SM, Shmulevich I, Ding L, Heins Z et al (2018) Oncogenic signaling pathways in the cancer genome atlas. Cell 173(2):321–337.e310. https://doi.org/10.1016/j.cell.2018.03.035
Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF (2015) Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res 35(6):600–604. https://doi.org/10.3109/10799893.2015.1030412
Lee C, Lee Y, Rice R (2005) Human epidermal cell protein responses to arsenite treatment in culture. Chemico-biological interactions 155.1:15543–15554. https://doi.org/10.1016/j.cbi.2005.04.004
Zhao F, Severson P, Pacheco S, Futscher B, Klimecki W (2013) Arsenic exposure induces the Warburg effect in cultured human cells. Toxicol Appl Pharmacol 271(1):72–77
Ruan Y, Fang X, Guo T, Liu Y, Hu Y, Wang X, Hu Y, Gao L, Li Y, Pi J, Xu Y (2022) Metabolic reprogramming in the arsenic carcinogenesis. Ecotoxicol. Environ Saf 229:229113098. https://doi.org/10.1016/j.taap.2013.04.020
Kumar Y, Tapuria N, Kirmani N, Davidson B (2007) Tumour M2-pyruvate kinase: a gastrointestinal cancer marker. Eur J Gastroenterol Hepatol 19(3):265–276. https://doi.org/10.1097/MEG.0b013e3280102f78
Otto A (2016) Warburg effect(s)-a biographical sketch of Otto Warburg and his impacts on tumor metabolism. Cancer & metabolism 4:45. https://doi.org/10.1186/s40170-016-0145-9
Wu S, Le H (2013) Dual roles of PKM2 in cancer metabolism. Acta biochimica et biophysica Sinica 45(1):27–35. https://doi.org/10.1097/MEG.0b013e3280102f78
Wang L, Lu Y, Wang C, Xie Y, Zhao Y, Qian Y, Liu W, Wang M, Jiang B (2020) HB-EGF activates the EGFR/HIF-1α pathway to induce proliferation of arsenic-transformed cells and tumor growth. Frontiers in oncology 10:101019. https://doi.org/10.3389/fonc.2020.01019
Prigione A, Rohwer N, Hoffmann S, Mlody B, Drews K, Bukowiecki R, Blümlein K, Wanker E, Ralser M, Cramer T, Adjaye J (2014) HIF1α modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1-3 and PKM2. Stem cells (Dayton, Ohio) 32(2):364–376. https://doi.org/10.1002/stem.1552
Yang W, Zheng Y, Xia Y, Ji H, Chen X, Guo F, Lyssiotis C, Aldape K, Cantley L, Lu Z (2012) ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nature cell bio 14(12):1295–1304. https://doi.org/10.1002/stem.1552
Christofk H, Vander Heiden M, Harris M, Ramanathan A, Gerszten R, Wei R, Fleming M, Schreiber S, Cantley L (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452(7184):230–233. https://doi.org/10.1016/j.cmet.2015.01.017
Brinck U, Eigenbrodt E, Oehmke M, Mazurek S, Fischer G (1994) L- and M2-pyruvate kinase expression in renal cell carcinomas and their metastases. Virchows Archiv : an int j pathol 424(2):177–185. https://doi.org/10.1007/BF00193498
Wong N, Ojo D, Yan J, Tang D (2015) PKM2 contributes to cancer metabolism. Cancer lett 356:356184–356191. https://doi.org/10.1016/j.canlet.2014.01.031
Liu Y, Song D, Liang D, Li Y, Yan Y, Sun H, Zhang M, Hu J, Zhao Y, Liang Y, Li Y, Yang Z, Wang R, Zheng H, Wang P, Xie S (2022) Oncogenic TRIB2 interacts with and regulates PKM2 to promote aerobic glycolysis and lung cancer cell procession. Cell death disc 8(1):306. https://doi.org/10.1038/s41420-022-01095-1
Yang W, Xia Y, Ji H, Zheng Y, Liang J, Huang W, Gao X, Aldape K, Lu Z (2017) Corrigendum: nuclear PKM2 regulates β-catenin transactivation upon EGFR activation. Nature 550(7674):142. https://doi.org/10.1038/nature24008
Wang Y, Liu J, Jin X, Zhang D, Li D, Hao F, Feng Y, Gu S, Meng F, Tian M, Zheng Y, Xin L, Zhang X, Han X, Aravind L, Wei M (2017) O-GlcNAcylation destabilizes the active tetrameric PKM2 to promote the Warburg effect. PNAS 114(52):13732–13737. https://doi.org/10.1073/pnas.1704145115
Liang Y, Qian Y, Tang J, Yao C, Yu S, Qu J, Wei H, Chen G, Han Y (2022) Arsenic trioxide promotes ERK1/2-mediated phosphorylation and degradation of BIM to attenuate apoptosis in BEAS-2B cells. Chem Biol Interact 369:110304. https://doi.org/10.1016/j.cbi.2022.110304
Wang D, Xu H, Fan L, Ruan W, Song Q, Diao H, He R, Jin Y (2022) Hyperphosphorylation of EGFR/ERK signaling facilitates long-term arsenite-induced hepatocytes epithelial-mesenchymal transition and liver fibrosis in sprague-dawley rats. Ecotoxicology and environmental safety 249:114386. https://doi.org/10.1016/j.cbi.2022.110304
Jin P, Zhou Q, Xi S (2022) Low-dose arsenite causes overexpression of EGF, TGFα, and HSP90 through Trx1-TXNIP-NLRP3 axis mediated signaling pathways in the human bladder epithelial cells. Ecotoxicology and environmental safety 247:114263. https://doi.org/10.1016/j.ecoenv.2022.114263
Funding
This work was supported by the National Natural Science Foundation of China (81673109) and the National Natural Science Foundation of China (No. 81830099).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Fig. S1:
2-DG antagonized low dose of arsenic-induced proliferation of L-02 cells. The effects of 0.2 μmol/L As3+ and/or 2-DG were detested using the Cell-Light EdU Apollo in vitro imaging kit. Data from three independent experiment are shown. *p<0.05 vs. control group. (PNG 728 kb)
Fig. S2:
U0126 inhibited the activation of ERK signaling pathway induced by low dose of arsenic. a The effects of treatment with 0.4 μmol/L As3+ on the level of phospho-ERK and ERK were detected using Western blot. Data from three independent experiment are shown; b The effects of 0.2 μmol/L As3+and/or U0126 were detected using Western blot. Data from three independent experiment are shown. *p<0.05 vs. control group. (PNG 368 kb)
Fig. S3:
U0126 antagonized low dose of arsenic-induced proliferation of L-02 cells. The effects of 0.2 μmol/L As3+ and/or U0126 were detested using the Cell-Light EdU Apollo in vitro imaging kit. Data from three independent experiment are shown. *p<0.05 vs. control group. (PNG 1139 kb)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yin, F., Zhang, X., Zhang, Z. et al. ERK/PKM2 Is Mediated in the Warburg Effect and Cell Proliferation in Arsenic-Induced Human L-02 Hepatocytes. Biol Trace Elem Res 202, 493–503 (2024). https://doi.org/10.1007/s12011-023-03706-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-023-03706-z